Trans-differentiation of the adipose tissue-derived stem cells into neuron-like cells expressing neurotrophins by selegiline

Iranian Biomedical Journal

Volumn 15, Issue 4, 2011, Pages 113-121

  Abdanipour, Alireza ^a   Tiraihi, Taki ^a,b   Delshad, AliReza ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b Khatam Al Anbia Hospital   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Neurotrophin; Selegiline; Transdifferentiation

Indexed keywords

ALPHA4 INTEGRIN; CD31 ANTIGEN; CD45 ANTIGEN; NESTIN; NEUROFILAMENT 68 PROTEIN; NEUROFILAMENT PROTEIN; NEUROTROPHIN; SELEGILINE; SYNAPSIN; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; FM1 43; NERVE GROWTH FACTOR; PYRIDINIUM DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL TRANSDIFFERENTIATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INCUBATION TIME; LIPOGENESIS; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NISSL SUBSTANCE; STEM CELL;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; NERVE GROWTH FACTORS; NEURONS; NISSL BODIES; OSTEOGENESIS; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; RATS; SELEGILINE; STAINING AND LABELING; STEM CELLS;

EID: 84866745263     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/IBJ.1011.2012     Document Type: Article

References (32)

1. Pachón-Peña, G., Yu, G., Tucker, A., Wu, X., Vendrell, J., Bunnell, B.A. and Gimble, J.M. (2011) Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immune-phenotypic profiles. J. Cell Physiol. 226: 843-51.
2. Zuk, P.A., Zhu, M., Ashjian, P., Urgate, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P. and Hedrick, M.H. (2002) Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13: 4279-4295.
3. Gimble, J.M., Katz, A.J. and Bunnell, B.A. (2007) Adipose-derived stem cells for regenerative medicine. Circ. Res. 100: 1249-1260.
4. Huang, T., He, D., Kleiner, G. and Kuluz, J. (2007) Neuron-like differentiation of adipose-derived stem cells from infant piglets in vitro. J. Spinal Cord Med. 1: S35-40.
5. Zhang, D.Z., Gai, L.Y., Liu, H.W., Jin, Q.H., Huang, J.H. and Zhu, X.Y. (2008) Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction. Chin. Med. J. (Engl). 120: 300-307.
6. Barzilay, R., Melamed, E. and Offen, D. (2009) Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells 27: 2509-2515.
7. Sanchez-Ramos, J.R. (2002) Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosc. Res. 69: 880-893.
8. Safford, K.M. and Rice, H.E. (2005) Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived stem cells. Curr. Drug Targets 6: 5762.
9. Amsterdam, J.D. (2003) A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J. Clin. Psych. 64: 208-214.
10. Magyar, K. and Szende, B. (2004) (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicol. 25: 233-242.
11. Knoll, J. (2000) (-)Deprenyl (Selegiline): past, present and future. Neurobiol. 8: 179-199.
12. Esmaeili, F., Tiraihi, T., Movahedin, M. and Mowla, S.J. (2006) Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells. Rejuvenation Res. 9: 475-484.
13. Rodbell, M. (1964) Localization of lipoprotein lipase in fat cells of rat adipose tissue. J. Biol. Chem. 239: 753755.
14. Eslaminejad, M.B., Nikmahzar, A., Taghiyar, L., Nadri, S. and Massumi, M. (2006) Murine mesenchymal stem cells isolated by low density primary culture system. Dev. Growth Differ. 48: 361-370.
15. Zhang, Y., Wang, J., Chen, G., Fan, D. and Deng, M. (2011) Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem. Biophys. Res. Commun. 404: 610-614.
16. Johnson, J.M. and Betz, W.J. (2008) The color of lactotroph secretory granules stained with FM1-43 depends on dye concentration. Biophys. J. 94: 3167-3177.
17. An, Y., Tsang, K.K. and Zhang, H. (2006) Potential of stem cell based therapy and tissue engineering in the regeneration of the central nervous system. Biomed. Mater. 1: R38-R44.
18. Lindvall, O. and Björklund, A. (2004) Cell replacement therapy: helping the brain to repair itself. NeuroRx. 1: 379-381.
19. Dazzi, F., Ramasamy, R., Glennie, S., Jones, S.P. and Roberts, I. (2006) The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 20: 161-171.
20. Sylvester, K.G., and Loganker, M.T. (2004) Stem cells. Arch. Surg. 139: 93-99.
21. Fraser, J.K., Wulur, I., Alfonso, Z. and Hedrick, M.H. (2006) Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 24: 150-154.
22. Stolzing, A., Jones, E., McGonagle, D. and Scutt, A. (2008) Age-related changes in human bone marrowderived mesenchymal stem cells: Consequences for cell therapies. Mech. Ageing Dev. 129: 163-173.
23. Lin, L., Shen, Q., Wei, X., Hou, Y., Xue, T., Fu, X., Duan, X. and Yu, C. (2009) Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects. Calcif Tissue Int. 85: 55-65.
24. Tapp, H., Hanley, E. N, Patt, J.C. and Gruber, H.E. (2009) Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp. Biol. Med. (Maywood) 234:1-9.
25. Scherzed, A., Hackenberg, S., Froelich, K., Radeloff, A., Technau, A., Kessler, M., Hagen, R., Rak, K., Koehler, C. and Kleinsasser, N. (2011) The effect of wound fluid on adipose-derived stem cells in vitro: a study in human cell materials. Tissue Eng. Part C Meth. 17: 809-817.
26. Fraser, J.K., Schreiber, R., Strem, B., Zhu, M., Alfonso, Z., Wulur, I. and Hedrick, M.H. (2006) Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat. Clin. Pract. Cardiovasc. Med. 1: S33-S37.
27. Knoll, J. (1997) History of deprenyl: the first selective inhibitor of monoamine oxidase type B. Vopr Med. Khim. 43: 482-493.
28. Ghorbanian, M.T., Tiraihi, T., Mesbah-Namin, S.A. and Fathollahi, Y. (2010) Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype. Neurol. Res. 32:185-193.
29. Nagatsu, T. and Sawada, M. (2006) Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. J. Neural. Transm. Suppl. 71: 53-65.
30. Sanchez-Romos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T.B., Saporta, S., Janseen, W., Patel, N., Cooper, D.R. and Sanberg, P.R. (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 164: 247-256.
31. Woodbury, D., Schwarz Emily, J and Ira, B. (2002) Adult Rat and human bone marrow stromal stem cells differentiate into neurons. J. Neurosci. Res. 61: 364-370.
32. Panahi, M., Al-Tiraihi, T. (2002) Morphometric evaluation of the neuroprotective effect of deprenyl on postaxotomic motor neuron losses. Clin Neuropharmacol. 25: 75-78.